Atlas Trials

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Clinical trial NCT02380274 · COMPLETED

Trial details

NCT number
NCT02380274
Sponsor
Astellas Pharma Global Development, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Start date
2015-03-27
Primary completion
2021-01-14
Enrollment
1030

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.